Elevance beats estimates, lifts 2026 guidance
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Elevance Health reported third-quarter adjusted earnings per share of $6.99 and operating revenue of $50.4 billion, topping analyst expectations. The insurer raised full-year 2026 adjusted EPS guidance to at least $29.00 and lifted its operating cash flow outlook. Shares rose 1.1% after the announcement. Stronger Medicare Advantage and Individual ACA results support the earnings upgrade for investors.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.